The Peptide Craze Ground Truths FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved FDA mulls compounding for peptides previously flagged over safety risks BioSpace BPC 157: The peptide with big claims and scant evidence STAT